Cardinal Health (CAH) Tops Q1 EPS by 9c, Reaffirms FY18 EPS Guidance
Get Alerts CAH Hot Sheet
Price: $247.18 -0.58%
Revenue Growth %: +4.2%
Financial Fact:
Litigation (recoveries)/charges, net: 1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.2%
Financial Fact:
Litigation (recoveries)/charges, net: 1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cardinal Health (NYSE: CAH) reported Q1 EPS of $1.09, $0.09 better than the analyst estimate of $1.00. Revenue for the quarter came in at $32.6 billion versus the consensus estimate of $33.48 billion.
The company reaffirms its fiscal year 2018 guidance range for non-GAAP diluted EPS of $4.85 to $5.10.
For earnings history and earnings-related data on Cardinal Health (CAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share